Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
Clinical trial NCT06502249 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06502249
- Sponsor
- Ain Shams University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.